Act Fast to Get the Incredible Beats Fit Pro Earbuds for Just $110
If you want some of the best workout earbuds that also happen to be some of the best noise-canceling earbuds and best earbuds overall, then you'd probably be expecting to pay a huge amount of money. It doesn't have to be like that though.
Right now on Woot, you can get your hands on the incredible Beats Fit Pro while they're down to just $110, which is a $90 discount on the normal price. That's a genuinely great sale, and also the lowest price we've ever seen for them.
These sleek true wireless earbuds feature a stemless design with flexible wing tips that keep them securely in place, even during your most rigorous workouts. Plus, they boast an IPX4 weather-resistance rating, so they're protected against sweat and splashing.
Hey, did you know? CNET Deals texts are free, easy and save you money.
Internally, they're equipped with Apple's H1 chip, which provides excellent noise-cancelling capabilities and spatial audio support. They also have a transparency mode for when you need to be more aware of your surroundings, and get up to 24 hours of playback time per charge. This is definitely one of the best earbuds deals you're going to see for a while.
Why this deal matters
Earning a spot on multiple lists of the best earbuds of 2025, the Beats Fit Pro are one of the absolute best pairs on the market right now. Which means that — even at full price — they're still a pretty good value. So they're an incredible bargain now that you can pick them up at a record-low price.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
27 minutes ago
- Forbes
Google's Next Pixel Update—Apple's iPhone Falls Behind
Apple has some catching up to do. Smartphones are now under threat from malicious text messages, attacks that come courtesy of China's organized criminal gangs. Whether its an unpaid toll or a DMV traffic offense or even an undelivered package, the threat is the same. Google warns that these dangerous texts can be sent directly to your phone rather than via a mobile network, and that users should disable 2G networks to stay safe. Those so-called SMS-blaster attacks trick your phone into connecting to a malicious device, thinking it's a legitimate cellular access point. That same kind of trickery can do more than just blast texts, it can actually intercept all traffic to and from the phone. You'll have heard of police use of so-called Stingrays — that's what this is. Network defense at work. Not only does Google enable 2G connections to be disabled where iPhone does not, but the Android-maker is now also launching a defense against these rogue cellular connections, warning when there's any unencrypted connection or when a network is repeatedly pinging a phone for its identifiers. Again, iPhone cannot do the same. I've reported on this before, but with the release of Android 16 it's now imminent — with a catch. As Android Authority points out, 'it's unlikely that any current devices will be updated to support the notifications feature. We will most likely have to wait for upcoming devices that launch with Android 16, such as the Pixel 10 series.' That's because this only works through an interface between the cellular modem and the phone's Android OS, and that's not expected to be available as an aftermarket upgrade. It also requires new modems capable of running the interface software. iPhones, by contrast, have to rely on filtering texts from unknown senders. Network defense at work. Android users with the right hardware — as and when it's available — should enable this protection. They should also disable 2G network connections and also enable Android 16's new Advanced Protection Mode, which — not be accident — disables 2G by default. With the network defense and Advanced Protection Mode upgrades, Google is seriously raising the bar for Android users. Apple's iPhone is materially behind when it comes to network protection, albeit remains ahead when it comes to phone lockdowns, malware defenses, sandboxing apps and policing data harvesting permissions. The gap between the two operating systems has never been narrower. A current Android phone with these protections enabled gives iPhone a run for its money for the first time. At least as regards external threats. You still need to be comfortable with Google's own tracking and data harvesting, and its expansive use of Gemini.
Forbes
34 minutes ago
- Forbes
Apple iPhone 17 Air: Did Apple Just Accidentally Leak A Key Design Detail?
Apple recently released its second developer beta of the next iPhone software, iOS 26. It's what the iPhone 17 series will run on when the handsets are released. But it looks like Apple has given something away about one of the new phones, perhaps by mistake. Has Apple just revealed what the display on the iPhone 17 "Air" will look like? As spotted by Macworld, deep in the code for the latest developer beta is a new version of the popular clownfish iPhone wallpaper. So what, you might say, that's nothing new. Except this one is. The new wallpaper has 'a resolution of '420×912@3x,' or 1260×2736 pixels. There's no iPhone model with such a resolution, at least not yet,' the report pointed out. That's pretty clear that one of the iPhones in development will have this all-new screen size, which ties in perfectly with the reports that have leaked about the super-slim iPhone in development, nicknamed iPhone 17 Air. 'The new resolution wallpaper we found matches a report by analyst Ming-Chi Kuo last year, which claimed that the iPhone 17 Air would have a screen of around 6.6 inches with a resolution of approximately 1260×2740. In other words, the wallpaper all but confirms the existence of a new iPhone model with that exact display resolution. Given that iOS 26 will almost certainly be released in September along with the new iPhones, it's clear that Apple is already making the final adjustments for the next-generation iPhone,' Macworld explained. The publication even suggests the new wallpaper was left in the beta entirely by accident: 'Since other iOS 26 wallpapers don't have that resolution, most likely the wallpaper was forgotten by Apple within the build released today for developers and shouldn't be seen by the public,' it said. Well, the truth is you never know with Apple. Could they have planted it in the beta to get everyone talking? Personally, I adhere to the cock-up theory of history rather than the conspiracy one, but who knows? The Prompt: Get the week's biggest AI news on the buzziest companies and boldest breakthroughs, in your Subscribed! You're Subscribed! If it vanishes when the third beta is released, it may indicate a mistake. Either way, it seems to double down on the belief that the iPhone 17 Air will have a 6.6-inch display, which is good to know.
Medscape
41 minutes ago
- Medscape
A Simple Way to Close Racial Gaps in Cancer Trial Enrollment
TOPLINE: In a single-center survey, patients with breast cancer from different racial and ethnic backgrounds were equally likely to discuss and participate in clinical trials when given the opportunity. Among patients who declined to participate, ineligibility and time commitment emerged as key barriers. METHODOLOGY: Clinical trials are crucial for advancing breast cancer care, but enrollment among Black and Hispanic women remains disproportionately low, resulting in study populations that do not reflect the diversity of patients with breast cancer. Some studies suggest that when given the opportunity, Black and Hispanic patients are just as willing to participate in clinical trials as their White counterparts. To better understand discussions, participation as well as patient attitudes surrounding clinical trials, researchers analyzed survey responses from 1150 patients with breast cancer who were enrolled in the Chicago Multiethnic Epidemiologic Breast Cancer Cohort and responded to a survey between July and September 2022. Among them, 4.4% were Asian, 19.5% Black, 3.1% Hispanic, and 73.0% White individuals; mean age at diagnosis was just under 54 years. Compared with White patients, Black patients had increased proportions of triple-negative breast cancer (TNBC; 14.6% vs 25.0%) and grade 3 tumors (36.9% vs 55.5%). Outcomes of interest were discussions of clinical trials, actual participation, and barriers to participation. TAKEAWAY: Among survey respondents, 447 (38.9%) reported discussing trial participation with healthcare practitioners, with no significant differences between different racial/ethnic groups (adjusted odds ratios, 0.75 for Asian, 1.31 for Black, 0.73 for Hispanic patients compared to White patients). Of the 443 patients who were offered trials, 64.3% participated. Patients who were younger, had more advanced disease, or were diagnosed with TNBC or high-grade cancer were more likely to be offered a clinical trial. While there were differences in trial participation rates across racial and ethnic groups, they were not significantly different after adjusting for sociodemographic and clinical factors. Among 158 patients who declined to participate, the primary reasons were ineligibility and lack of interest in trials (23.4% for both) as well as concerns about receiving placebo (10.8%) and the time requirement (10.1%). Patients with an annual household income below $150,000 were also significantly less likely to participate than those with an income of $150,000 or more but this association varied by income bracket, suggesting that financial barriers are more nuanced than annual income alone. IN PRACTICE: The study adds to evidence that patients from racial minority groups are just as willing to enroll in clinical trials when given the chance, according to an invited commentary by Joseph M. Unger, PhD, MS, Fred Hutch Cancer Center, Seattle. The results also 'lend crucial validation' to prior findings showing that structural and clinical barriers — not patient refusal — are the main reasons for trial non-participation, according to Unger. 'Reducing barriers to enrollment of clinical trials is a scientific and ethical imperative for the cancer community,' the study authors said. SOURCE: This study, led by Nan Chen, MD, University of Chicago, Illinois, was published online in JAMA Network Open. LIMITATIONS: The study population may not have fully represented the broader population of patients with breast cancer in the US. The analysis also lacked sufficient statistical power to detect significant differences in clinical trial discussion and participation between Asian or Hispanic patients and White patients given limited sample sizes. Additionally, survey-based data collection may have introduced selection bias as respondents were likely healthier or had positive experiences with clinical trial discussion or participation. DISCLOSURES: This study was supported partly by grants from the Breast Cancer Research Foundation, National Cancer Institute, Susan G. Komen Breast Cancer Foundation, and National Institute on Aging. Two authors reported receiving personal fees or grants from various sources, outside the submitted work. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
